<DOC>
	<DOCNO>NCT00406341</DOCNO>
	<brief_summary>The purpose phase 3 study determine difluprednate ophthalmic emulsion effective treatment postoperative inflammation .</brief_summary>
	<brief_title>Study Difluprednate Ophthalmic Emulsion Postoperative Inflammation</brief_title>
	<detailed_description>The objective phase 3 study ass efficacy safety 0.05 % difluprednate ophthalmic emulsion patient intraocular postoperative inflammation .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Difluprednate</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<criteria>Patients undergone cataract surgery , vitreous surgery ( include patient undergone IOL insertion surgery time ) Patients show anterior chamber cell score less “ 2 ” day surgery Patients age 20 year , irrespective gender ( eligible enrollment patient ’ age attains criterion day consent obtainment ) Patients take systemic administration corticosteroid immunosuppressive agent , use ophthalmic ointment corticosteroid within 1 week instillation investigational drug ; Patients underwent local injection corticosteroid eye instillation investigational drug ; ( patient use aqueous preparation within 1 week patient use depot preparation within 2 week exclude ) Patients take systemic administration nonsteroidal antiinflammatory agent antiinflammatory enzyme preparation within 3 day instillation investigational drug ; Patients instilled corticosteroid , nosteroidal antiinflammatory agent antiinflammatory enzyme preparation within 24 hour preinstillation observation ( day surgery ) ; Patients underwent perioperative and/or postoperative intravitreous injection corticosteroid ; Patients underwent subconjunctival injection subTenon capsule injection corticosteroid ; Patients intraocular hemorrhage degree may affect postoperative evaluation ; Patients underwent gas tamponade surgery ; Patients endogenous uveitis ; Patients corneal epithelial detachment corneal ulcer target eye ; Patients suspect viral , bacterial mycotic keratoconjunctival disorder target opposite eye ; Patients glaucoma ocular hypertension , past history IOP increase due instillation corticosteroid , whose IOP control use ophthalmic antihypertensive agent ; Patients show IOP le 25 mmHg day surgery ; Patients allergy corticosteroid drug ; Patients require wear contact lens study period ; Patients schedule undergo surgery opposite eye study period ; Patients pregnant may pregnant lactating ; Patients participate clinical study within 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>